[HTML][HTML] First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era
A Urso, F Cavazzini, MP Ballardini, S Gambara… - Cancers, 2023 - mdpi.com
Simple Summary The modern treatment of chronic lymphocytic leukemia (CLL) has
dramatically changed thanks to the development of effective mechanism-based drugs, which …
dramatically changed thanks to the development of effective mechanism-based drugs, which …
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV …
VS Barber, N Peckham, L Duley, A Francis… - BMJ open, 2023 - bmjopen.bmj.com
Introduction People who are immunocompromised have a poor biological response to
vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia …
vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia …
[HTML][HTML] Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library
JT Markowitz, F Mazerolle, T Lovell, LM Hess… - Journal of Patient …, 2024 - Springer
Background No specific measures exist to assess patient-reported symptoms experienced
by individuals with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) …
by individuals with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) …
[HTML][HTML] Delving into Causal Discovery in Health-Related Quality of Life Questionnaires
M Ganopoulou, E Kontopoulos, K Fokianos… - Algorithms, 2024 - mdpi.com
Questionnaires on health-related quality of life (HRQoL) play a crucial role in managing
patients by revealing insights into physical, psychological, lifestyle, and social factors …
patients by revealing insights into physical, psychological, lifestyle, and social factors …
[HTML][HTML] Protocol: Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide …
VS Barber, N Peckham, L Duley, A Francis… - BMJ Open, 2023 - ncbi.nlm.nih.gov
Introduction People who are immunocompromised have a poor biological response to
vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia …
vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia …
Patient reported outcome measures in Waldenström macroglobulinaemia: a real‐world data analysis from the WMUK Rory Morrison Registry
J Khwaja, E Uppal, S Bristogiannis, H McCarthy… - …, 2023 - Wiley Online Library
Waldenström macroglobulinaemia (WM) is an incurable chronic B‐cell malignancy, but
highly responsive to treatment. Treatments include fixed‐duration chemotherapy and …
highly responsive to treatment. Treatments include fixed‐duration chemotherapy and …
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27
S Oerlemans, F Efficace, O Shamieh… - Blood …, 2023 - ashpublications.org
Hodgkin lymphoma (HL) has become 1 of the most curable cancers. Therefore, rigorous
assessment of health-related quality of life (HRQoL) and symptom burden of these patients …
assessment of health-related quality of life (HRQoL) and symptom burden of these patients …
International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL …
S Oerlemans, F Efficace, C Kyriakou, AC Freitas… - Cancer, 2023 - Wiley Online Library
Background Health‐related quality of life (HRQOL) is a critical aspect to consider when
making treatment decisions for patients with non‐Hodgkin‐lymphoma (NHL). This …
making treatment decisions for patients with non‐Hodgkin‐lymphoma (NHL). This …